Cargando…
Reversible and Non-Competitive Inhibition of Cyclooxygenase by Indobufen for Efficient Antiplatelet Action and Relief of Gastrointestinal Irritation
Clinically, indobufen is widely used for the treatment of antiplatelet aggregation and anticoagulation. Prior studies have discovered that abnormal platelet function can be promptly restored to normal when the drug is stopped. Herein, through the study of the enzyme reaction kinetics, we demonstrate...
Autores principales: | Liu, Jia, Sun, Peng, Qi, Xiaole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458679/ https://www.ncbi.nlm.nih.gov/pubmed/37631348 http://dx.doi.org/10.3390/pharmaceutics15082135 |
Ejemplares similares
-
Anticoagulant Activities of Indobufen, an Antiplatelet Drug
por: Liu, Jia, et al.
Publicado: (2018) -
Prediction of the human in vivo antiplatelet effect of S- and R-indobufen using population pharmacodynamic modeling and simulation based on in vitro platelet aggregation test
por: Noh, Yook-Hwan, et al.
Publicado: (2018) -
Comparison of the Effects of Indobufen and Warfarin in a Rat Model of Adenine-Induced Chronic Kidney Disease
por: Lou, Xiaowei, et al.
Publicado: (2019) -
Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
por: Pan, Yuesong, et al.
Publicado: (2022) -
Comparison of the prophylactic antithrombotic effect of indobufen and warfarin in patients with nephrotic syndrome: a randomized controlled trial
por: Gao, Xin-Yi, et al.
Publicado: (2023)